Company valuation ยท Basic Materials
NGVT: Hold with a $64.22 price target
Ingevity Corp. The company returned to profit, but the profit margin narrowed.
- Model target ยท USD
- $64.22 For 2027-09-16
- Model rating
- Hold Reviewed 2026-09-16
- Reference weekly close
- $69.41 2026-09-11 ยท USD

Investment view
The company returned to profit, but the profit margin narrowed.
Target and reference price
Target for 2027-09-16: $64.22 USD, -7.5% versus the $69.41 weekly close on 2026-09-11. Price return only; dividends, fees and tax excluded.
Price and earnings
Over 1 year (2025-09-12 to 2026-09-11), price changed +19.4% and trailing EPS changed +9.0%. A wider gap changes the earnings multiple; it does not establish fair value.
Supporting evidence
Net income was 35.3m, compared with -146.5m in the same quarter last year. Amounts are in USD.
Cash after capital spending / profit: 2.9ร for NGVT, against 0.9ร across 9 comparable peers.
Risks to the case
The latest quarterly operating margin was 19.1%, -6.8 percentage points from a year earlier. The full report separates sales growth from margin changes.
Revenue changed -5.2% from the same quarter last year, through 2026-06-30. The previous quarterโs year-on-year change was +4.1%.
What to monitor
The latest quarterly margin changed -6.8 percentage points from a year earlier. Check sales volumes, pricing and unusual gains in the next filing.
Recheck the valuation gap alongside profitability and growth after new results. A discount alone does not establish value.
Compare the stock and the market fund over the same dates. Look for a change in relative performance as results arrive.
Valuation assumptions
Starting annual sales growth: -1.66%.
Long-term operating margin: 32.58%.
About this assessment
Review recorded on 2026-09-16. This is a dated summary of an automated company valuation. The full report includes the financial evidence, alternative scenarios and review history. Consult the latest report before using an earlier target. Automated model research, not personal investment advice. Targets depend on assumptions; returns are not guaranteed.